학술논문
Pre-treatment immune status predicts disease control in NSCLCs treated with chemoradiation and durvalumab
Document Type
Article
Author
Source
In: Radiotherapy and Oncology . (Radiotherapy and Oncology, February 2022, 167:158-164)
Subject
Language
English
ISSN
18790887
01678140
01678140